Live News Categoriesequity

IMPACT Therapeutics, Inc (7630.HK) News

Track canonical SquawkNews coverage tagged to 7630.HK, IMPACT Therapeutics, Inc. This hub brings together deduplicated headlines about hkse, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol 7630.HK Asset equity Sector Markets 90 days 1 Last 13.03 Updated Sep 18, 2026, 03:37 PM UTC Open live news feed

L BRIEF — Impact Therapeutics Says Senaparib Submitted To European Commission For Final Marketing Authorization Decision Sept 18 (Reuters) — IMPACT Therapeutics Inc: Senaparib Submitted To European Commission For Final Marketing Authorization Decision Further company coverage: 7630.HK (Reuters.Briefs@thomsonreuters.com;) NEWS | Sep 18, 2026, 03:37 PM UTC